|
|
Article: Industry Responding Better To Bird Flu Than BioShield.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Washington Editor
WASHINGTON - By most measures, the federal government has had more success with drawing the drug industry to the pandemic flu issue than to biodefense. The question is, Why?
Some observers point to a learning curve. The Department of Health and Human Services, the principal government agency in charge of dispersing dollars to address both of the threats, has learned lessons from Project BioShield and applied them to better handle pandemic flu-related programs.
For example, HHS decided not to put all its eggs in one basket, and instead recently doled out more than $1 billion worth of contracts to five companies for cell-based ...
Related newspaper, magazine, and journal articles:
|
|
Article: COMPANY FORGING AHEAD WITH DIABETES DRUG AMYLIN STOCK DROPS 77 ...
BIOWORLD Today;
October 22, 1998 ;
700+ words
... ... price dropped below $8.50. (See BioWorld Today, Aug. 19, 1997, p. 1.) Along ... U.S. and Europe," Krawiec told BioWorld Today. Tanner said Amylin's move to continue ... J $36 million from a loan. (See BioWorld Today, March 3, 1998, p. 1.) Terms ...
|
|